Anthony Mack
Founder chez IACTA Pharmaceuticals, Inc.
Fortune : 1 M $ au 31/03/2024
Profil
Anthony P.
Mack is the founder of three pharmaceutical companies.
He founded ProSolus Pharmaceuticals LP in 2009, SCILEX Pharmaceuticals, Inc. in 2011, and Virpax Pharmaceuticals, Inc. in 2016.
At ProSolus Pharmaceuticals LP, he held the title of President & Director from 2009 to 2015.
At SCILEX Pharmaceuticals, Inc., he held the title of Chief Executive Officer & Director from 2011 to 2018.
At Virpax Pharmaceuticals, Inc., he held the title of Chairman & Chief Executive Officer from 2016 to 2023.
Mr. Mack is also the founder of IACTA Pharmaceuticals, Inc. Mr. Mack earned an MBA degree from St. Joseph's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIRPAX PHARMACEUTICALS, INC.
25,47% | 22/03/2024 | 298 298 ( 25,47% ) | 1 M $ | 31/03/2024 |
Postes actifs de Anthony Mack
| Sociétés | Poste | Début |
|---|---|---|
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Founder | - |
Anciens postes connus de Anthony Mack
| Sociétés | Poste | Fin |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Chief Executive Officer | 17/11/2023 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Founder | 01/02/2018 |
ProSolus Pharmaceuticals LP
 ProSolus Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Mission Pharmacal Co., ProSolus Pharmaceuticals LP is a private company that manufactures and supplies pharmaceutical products. The company is based in Miami, FL. The company was founded by Anthony P. Mack. ProSolus Pharmaceuticals was acquired by Mission Pharmacal Co. on June 09, 2015. | Founder | 01/06/2015 |
Formation de Anthony Mack
| St. Joseph's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
ProSolus Pharmaceuticals LP
ProSolus Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Mission Pharmacal Co., ProSolus Pharmaceuticals LP is a private company that manufactures and supplies pharmaceutical products. The company is based in Miami, FL. The company was founded by Anthony P. Mack. ProSolus Pharmaceuticals was acquired by Mission Pharmacal Co. on June 09, 2015. | Health Technology |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Health Technology |
